Results 151 to 160 of about 49,525 (269)

National consensus statement on opioid agonist treatment in custodial settings

Medical Journal of Australia, Volume 222, Issue 5, Page 262-268, March 2025.
Abstract Introduction Opioid use and dependence are prevalent among incarcerated people, contributing to elevated rates of overdose and other harms in this population. Opioid agonist treatment (OAT) has been shown to be an effective intervention to mitigate these risks. However, challenges to health care implementation in the custodial sector result in
Jocelyn Chan, Jon Cook, Michael Curtis, Adrian J Dunlop, Ele Morrison, Suzanne Nielsen, Rebecca J Winter, Thileepan Naren   +7 more
wiley   +1 more source

Disopyramide Cross-Reactivity in a Commercial Immunoassay Reagent for Methadone [PDF]

, 1999
Paul Moorman, Marcia McCoy, Bonnie Hague, Debbie Huge   +3 more
openalex   +1 more source

Prescription opioid supply‐restricting policies and hospital use by people prescribed opioid medications, Victoria, 2018–22: a controlled interrupted time series analysis

Medical Journal of Australia, EarlyView.
Abstract Objectives To investigate the combined effect of two policies for reducing prescription opioid supply in Australia on hospital use by people prescribed opioids in primary care. Study design Retrospective data linkage study; controlled interrupted time series analysis of linked primary care electronic medication records and hospital admissions ...
Suzanne Nielsen, Louisa Picco, Bosco Rowland, Nadine E Andrew, Taya A Collyer, Samanta Lalic, Rachelle Buchbinder, Christopher Pearce, J Simon Bell, Dan I Lubman, Ting Xia   +10 more
wiley   +1 more source

Rapid Titration of Methadone for Opioid Use Disorder in the Emergency Department: A Case Report. [PDF]

Clin Pract Cases Emerg Med
Lamberson M, King R, Waters CT, Jackson P, Brooklyn J, Riser E, Wolfson D.   +6 more
europepmc   +1 more source

Consensus panel proposes sweeping changes to improve access to methadone maintenance treatment [PDF]

, 1998

openalex   +1 more source

Treatment Experience Using a Micro‐Induction Buprenorphine Protocol for Chronic Pain in Pediatric Sickle Cell Disease

Pediatric Blood &Cancer, Volume 72, Issue 8, August 2025.
ABSTRACT Background Patients with sickle cell disease (SCD) experience painful vaso‐occlusive episodes that increase with age; a subset develops chronic pain (CP). CP is usually managed with acute pain management guidelines despite evidence of ineffectiveness.
Ashwin Patel, Grace Kalmus, Carlton Dampier, Ifeyinwa Osunkwo, Tamara New, Beatrice Gee, Elna Saah   +6 more
wiley   +1 more source

Benzodiazepines consumption in a sample of methadone-maintained patients: Characteristics of use and psychopathological profiles [PDF]

, 1998
Giovanni Forza, E. Levarta, Denise Da Ros, Nicola Gentile, Fabrizio Schifano   +4 more
openalex   +1 more source

Recovery support services as part of the continuum of care for alcohol or drug use disorders

Addiction, Volume 120, Issue 8, Page 1497-1520, August 2025.
Abstract Background The definition of ‘recovery’ has evolved beyond merely control of problem substance use to include other aspects of health and wellbeing (known as ‘recovery capital’) which are important to prevent relapse to problematic alcohol or other drug (AOD) use.
Ed Day, Laura Charlotte Pechey, Suzie Roscoe, John F. Kelly   +3 more
wiley   +1 more source

Quantifying the impact of a large‐scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data‐modeling study

Addiction, Volume 120, Issue 8, Page 1601-1609, August 2025.
Abstract Aims This study aimed to quantify the population‐level impact of a large‐scale opioid agonist treatment (OAT) program on suicide‐related mortality among people with opioid use disorder (OUD) in New South Wales (NSW), Australia. Design This is the first study to use dynamic mathematical modeling to explore the population‐level impact of OAT on ...
Thomas James Santo Jr, Antoine Chaillon, Natasha Martin, Matthew Hickman, Nicola Jones, Michael Farrell, Chrianna Bharat, Louisa Degenhardt, Annick Borquez   +8 more
wiley   +1 more source

High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study. [PDF]

Addict Sci Clin Pract
Mordal J, Juya F, Holtan L, Vederhus JK, Opheim A, Brenna IH, Enger AE, Weimand B, Solli KK, Tanum L.   +9 more
europepmc   +1 more source